iX Biopharma Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	0.87	1.77	6.52	13.49	6.21
Short-Term Investments	0.07	0.07	0.02	0.09	0.01
Cash & Short-Term Investments	0.94	1.84	6.53	13.59	6.21
Cash Growth	-49.27%	-71.79%	-51.91%	118.65%	8.03%
Accounts Receivable	1.03	1.29	1.25	0.5	0.22
Other Receivables	0.91	1.63	1.8	1.48	1.59
Receivables	1.94	2.92	3.05	1.98	1.82
Inventory	0.92	1.38	0.96	0.91	1.1
Prepaid Expenses	0.41	0.44	0.44	0.37	0.22
Total Current Assets	4.21	6.59	10.98	16.84	9.35
Property, Plant & Equipment	6.72	7.61	8.22	7.72	8.95
Long-Term Investments	-	0.01	3.87	2.26	-
Goodwill	0.27	0.29	0.29	0.31	0.33
Other Intangible Assets	-	0	-	0.04	0.09
Long-Term Deferred Tax Assets	-	-	1.38	1.28	-
Other Long-Term Assets	0.09	0.13	0.19	0.07	0.15
Total Assets	11.28	14.62	24.93	28.52	18.86
Accounts Payable	1.3	1.26	0.4	0.22	0.55
Accrued Expenses	2.99	2.87	2.81	2.31	2.31
Current Portion of Long-Term Debt	4.08	2.49	2.75	3.29	0.42
Current Portion of Leases	0.27	0.39	0.44	0.24	0.38
Current Income Taxes Payable	0.18	0.17	0.73	1.76	-
Other Current Liabilities	0.14	0.21	0.05	0.04	0.02
Total Current Liabilities	8.98	7.38	7.18	7.86	3.67
Long-Term Debt	1.47	2.18	0.57	0.88	3.2
Long-Term Leases	0.08	0.14	0.58	-	0.24
Other Long-Term Liabilities	0.39	0.58	0.76	0.04	0.04
Total Liabilities	10.92	10.28	9.08	8.77	7.15
Common Stock	100.83	97.45	97.23	94.18	83.34
Retained Earnings	-107.12	-96.98	-86.18	-76.57	-71.97
Comprehensive Income & Other	6.65	3.87	4.8	2.13	0.34
Shareholders' Equity	0.37	4.34	15.85	19.74	11.71
Total Liabilities & Equity	11.28	14.62	24.93	28.52	18.86
Total Debt	5.9	5.2	4.34	4.41	4.24
Net Cash (Debt)	-4.97	-3.36	2.2	9.18	1.98
Net Cash Growth	-	-	-76.08%	363.97%	7.91%
Net Cash Per Share	-0.01	-0.00	0.00	0.01	0.00
Filing Date Shares Outstanding	887.96	883.34	766.3	764.9	746.17
Total Common Shares Outstanding	887.96	768.32	766.3	751.19	697.35
Working Capital	-4.77	-0.8	3.8	8.99	5.68
Book Value Per Share	0.00	0.01	0.02	0.03	0.02
Tangible Book Value	0.1	4.05	15.56	19.4	11.3
Tangible Book Value Per Share	0.00	0.01	0.02	0.03	0.02
Land	2.38	2.57	2.56	2.73	2.88
Buildings	1.61	1.74	1.74	1.85	1.97
Machinery	6.7	6.99	6.71	6.6	7.13
Leasehold Improvements	0.71	0.76	0.74	0.64	0.25

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.